Drug and Gene Delivery


UVA is widely recognized for its strengths in biopanning for novel peptide ligands in vivo, as well as using peptides and antibodies to target the delivery of microbubbles, liposomes and genes in the settings of cancer, cardiovascular and infectious disease.  The combination of targeted drug and gene delivery with molecular imaging and systems biology provides a strong interdisciplinary foundation for the development and testing of novel targeted pharmaceuticals, as well as the revival and re-purposing of known small-molecule drugs with off-target effects that can now be corrected by targeted delivery.

Joint Faculty in Drug and Gene Delivery

  • Mark Kester, PhD

    Director of NanoStar and Professor of Pharmacology


    Developing innovative nanotechnologies for targeted drug delivery in cancer and cardiovascular diseases.

    Faculty Profile
  • Kyle Lampe, PhD

    Assistant Professor of Chemical Engineering


    Biomaterials for tissue engineering, regenerative medicine, and drug delivery within the central nervous system, developing both synthetic polymers and recombinant engineered proteins.

    Faculty Profile
  • Alexander (Sasha) Klibanov, PhD

    Associate Professor of Cardiovascular Medicine


    Pre-clinical research in the field of targeted imaging and drug delivery. Preparing and analyzing ultrasound contrast materials, attach targeting ligands (antibodies, peptides) and plasmid DNA to their surface for targeting and ultrasound-enhanced...

    Faculty Profile

More about Drug and Gene Delivery at UVA